Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic Therapy

Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic Therapy

Idiopathic pulmonary fibrosis (IPF) is characterized by uncontrolled progressive lung fibrosis with a median survival of 3 to 5 years. Although currently available pharmacotherapy cannot cure the disease, antifibrotics including pirfenidone and nintedanib were shown to slow disease progression and i...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebastian Majewski, Maria Królikowska, Ulrich Costabel, Wojciech J. Piotrowski, Marek Ochman
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Pulmonology
Online Access:http://dx.doi.org/10.1155/2022/4054339
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items